Pipeline: Clinical Trials


We are currently exploring the potential of our novel technology platform to harness the regenerative properties of a patient’s own skin across a number of dermatological indications.

Supported by a substantive body of clinical evidence and peer-reviewed publications, our late stage pipeline is focused on injuries and skin defects leveraging the RECELL® System.

AVITA Medical Clinical Trials

Current Clinical Trials

Feasibility Study to Evaluate RECELL® and Melanocyte Keratinocyte Transplantation Procedure for Repigmentation of Stable Vitiligo Lesions

Study: NCT04271501 on clinicaltrials.gov.

RECELL® System Combined With Meshed Autograft for Reduction of Donor Skin Harvesting in Soft Tissue Reconstruction

Study: NCT04091672 on clinicaltrials.gov.

RES® Prepared With RECELL® Compared to Standard of Care Dressings of Partial-thickness Burns in Ages 1-16 Years

Study: NCT03626701 on clinicaltrials.gov.

This website stores cookies on your computer. These cookies are used to improve your website experience and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, see our privacy policy.